Linearis Ventures
Venture capitalQuebec City · Seed–Series B · 3 people tracked
Investment thesis
Linearis combines a venture fund with a world-class metabolomics laboratory to invest in and support innovation across the AI-life science continuum. It backs companies advancing drug discovery, early diagnosis, disease prevention, and patient monitoring, aiming to prevent, detect, and cure diseases. Its tandem laboratory provides quantitative metabolomics analysis, disease-signature discovery, and AI analysis software to support portfolio companies and partners including BioPharma, CROs, biobanks, and clinical and academic institutions.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 3 of 3 portfolio companiesAI & Machine Learning ×2Biotech ×2Deep Tech ×1Digital Health ×1Healthtech ×1Medical Devices ×1
HQs:Canada×1United States×1
Investments · 3 tracked
founders shown can be your intro pathFeldan Therapeutics is a clinical-stage biotech company developing treatments based on intracellular delivery of therapeutics.
BiotechDeep Tech
Co-investorsGenesys Capital
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Jacob Rinaldi(Executive Officer, Director, Promoter)Ronald Alfa(Executive Officer, Director, Promoter)
BoardJames Hardiman(Director)inAmy Schulman(Director)in
Co-investors11.2 CapitalBreakout VenturesNorth South VenturesDCVC (Data Collective)Polaris Partners
Zilia develops eye-imaging technology that combines imaging, spectrometry, and artificial intelligence to detect and measure ocular biomarkers, including blood oxygen saturation, to support the prevention, diagnosis, and treatment of ocular, neurological, and systemic conditions.
AI & Machine LearningDigital HealthMedical Devices
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Linearis Ventures invest at?
- Linearis Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Linearis Ventures focus on?
- Linearis Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Linearis Ventures located?
- Linearis Ventures is headquartered in Quebec City, CA.
- Who does Linearis Ventures co-invest with?
- Linearis Ventures most often shares deals with 11.2 Capital, Breakout Ventures, Genesys Capital, among 4 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Rising Tide is a venture capital firm investing across sectors including healthcare, life sciences, AI infrastructure, space and communications, fintech, and crypto.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It backs transformative entrepreneurs building industry-defining technologies with global scale potential.